Evidence map›Paper›PMID 42506339›Full record

ArticleMedical sciences (Basel, Switzerland)2026

Role of Matrix Metalloproteinases and Tissue Inhibitors in Sepsis Pathogenesis.

Rasime Sevgi Cenan, Ayşegül Karaoğlan, Hatice Paşaoğlu

Abstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rasime Sevgi CenanDepartment of Clinical Biochemistry, Gazi University Hospital, 06560 Ankara, Turkey.ORCID 0000-0002-8008-4712
Ayşegül KaraoğlanDepartment of Clinical Biochemistry, Gazi University Hospital, 06560 Ankara, Turkey.
Hatice PaşaoğluDepartment of Clinical Biochemistry, Gazi University Hospital, 06560 Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study investigates the role of MMPs and TIMPs in sepsis pathogenesis. We aim to assess multiple potential biomarkers including MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, TIMP-1, TIMP-2, TIMP-3 in serum, brain and kidney tissue samples. To this date, there is not such extensive assessment of MMP and TIMP in sepsis pathogenesis.

methodsExperimental sepsis was generated using an LPS-induced endotoxemia model in rats. After 24 h, serum, brain and kidney samples were collected. Levels of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, and TIMP-1, TIMP-2, TIMP-3 were measured by ELISA. Inflammatory cytokines (TNF-α, IL-6, IL-10, and IFN-γ) were analyzed to assess the inflammatory response.

resultsAnalysis revealed that MMP-1 concentrations were elevated in kidney and brain tissues, as well as in serum in the sepsis group. MMP-2 levels exhibited statistically significant increases in brain tissues compared to controls. Elevations in MMP-3 were observed across brain, kidney and serum samples. MMP-8 levels were significantly increased in the serum. MMP-9 concentrations were higher in serum and kidney samples of septic rats compared with controls, while MMP-13 levels were elevated in kidney tissues of the sepsis group. TIMP measurements also revealed tissue-specific elevations in sepsis. TIMP-1 was significantly increased in kidney; TIMP-2 showed significant rises in brain tissue and serum; and TIMP-3 was markedly elevated in kidney tissues.

conclusionsA major strength of our study is the simultaneous assessment of multiple parameters. Our findings offer preliminary evidence of tissue-specific MMP and TIMP responses in sepsis and may guide future research exploring their biomarker potential. We anticipate that these results will inform both future clinical and pharmacological research and assist in the interpretation of subsequent studies.

Indexed as

Matrix MetalloproteinasesSepsisTissue Inhibitor of MetalloproteinasesAnimalsBiomarkersBrainCytokinesDisease Models, AnimalKidneyLipopolysaccharidesMaleRatsRats, Sprague-DawleyTissue Inhibitor of Metalloproteinase-2BiomarkersCytokinesLipopolysaccharidesMatrix MetalloproteinasesTissue Inhibitor of Metalloproteinase-2Tissue Inhibitor of Metalloproteinasesbiomarkersinflammationmatrix metalloproteinasessepsistissue inhibitors of matrix metalloproteinases

Identifiers

PMID42506339
PMCPMC13414454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.